TrialNutrients2020

Decrease in Mucosal IL17A, IFNγ and IL10 Expressions in Active Crohn's Disease Patients Treated with High-Dose Vitamin Alone or Combined with Infliximab.

Mia Bendix et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.